Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder-Reference-Cited by-同舟云学术

Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder

Published:2018-10-21 Issue:8 Volume:22 Page:e13302
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Kassa Csaba¹^ORCID,Reményi Péter²,Sinkó János²,Kállay Krisztián¹,Kertész Gabriella¹,Kriván Gergely¹

Affiliation:

1. Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest; National Institute of Hematology and Infectious Diseases; Budapest Hungary

2. Department of Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest; National Institute of Hematology and Infectious Diseases; Budapest Hungary

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.13302/fullpdf

Reference11 articles.

1. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines;Styczynski;Haematologica,2016

2. Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study;Lesokhin;J Clin Oncol,2016

3. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation;Styczynski;Clin Infect Dis,2013

4. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR;Hamadani;Bone Marrow Transplant,2007

5. Successful treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disease with central nervous system involvement following allogeneic haematopoietic stem cell transplantation - a case study;Wróblewska;Cent Eur J Immunol,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings;Radiology Case Reports;2024-06

2. The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for the management of post‐transplant lymphoproliferative disorders in children and adolescents;Pediatric Transplantation;2024-05-29

3. A disease warranting attention from neurosurgeons: primary central nervous system post-transplant lymphoproliferative disorder;Frontiers in Neurology;2024-05-15

4. Clinical Experiences with Immune Checkpoint Inhibitors in Lymphomas;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

5. Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature;Insights into Imaging;2024-02-14